What does Preamble of Gwenn’s Law do?

This bill directs the Secretary of Health and Human Services to implement a public awareness campaign. The campaign aims to increase participation by women in clinical trials. These clinical trials are conducted or supported by the National Institutes of Health.

What does SHORT TITLE. of Gwenn’s Law do?

This bill is formally titled Gwenn's Law.

What does PUBLIC AWARENESS CAMPAIGN TO INCREASE PARTICIPATION OF WOMEN IN of Gwenn’s Law do?

This section directs the Secretary of Health and Human Services, through the Director of the National Institutes of Health (NIH), to conduct a public awareness campaign. The campaign's purpose is to increase the participation of women in clinical trials conducted or supported by the NIH. Outreach efforts should be expanded to hospitals, physicians' offices, health centers, and other appropriate locations. The Secretary should prioritize increasing women's participation in clinical trials related to rare diseases and conditions. The section authorizes appropriations of $10,000,000 annually from fiscal years 2027 through 2031 to carry out the campaign.

What does PUBLIC AWARENESS CAMPAIGN TO INCREASE AWARENESS OF BLEEDING AND of Gwenn’s Law do?

This section directs the Secretary of Health and Human Services to conduct a public awareness campaign. The campaign's purpose is to increase female participation in Department of Health and Human Services programs related to research, surveillance, and prevention of bleeding and clotting disorders, including hemophilia. The section authorizes appropriations of $10,000,000 annually from fiscal years 2027 through 2031 to support the campaign.

What does INTERAGENCY TASK FORCE ON ADVANCING TREATMENTS FOR RARE of Gwenn’s Law do?

This section amends the Public Health Service Act to establish a permanent Interagency Task Force on Advancing Treatments for Rare Diseases. The Secretary is required to establish the Task Force within 90 days of the legislation's enactment. The Task Force will consist of the Secretary, the Administrator of the Centers for Medicare & Medicaid Services, the Commissioner of Food and Drugs, the Director of the National Institutes of Health, and the Director of the Centers for Disease Control and Prevention. The Secretary will appoint eight additional members: four biopharmaceutical innovators, private health plan administrators, or research institution representatives, and four representatives of rare disease advocacy groups. The Task Force's duties include assessing federal agency activities, programmatic funding, and potential measurable outcomes related to rare diseases. The Task Force will coordinate efforts to incentivize research and development of products for the prevention, diagnosis, and treatment of rare diseases, particularly those disproportionately impacting women.

What does ACTION PLAN FOR COORDINATING HHS EFFORTS WITH RESPECT TO of Gwenn’s Law do?

This section requires the Secretary of Health and Human Services to prepare an action plan for coordinating Department efforts. The action plan should incentivize research and development of products for prevention, diagnosis, and treatment of rare diseases and conditions. These rare diseases and conditions must disproportionately impact women. The Secretary must complete the action plan within 180 days of the Act's enactment. The plan must be submitted to Congress and made publicly available on the websites of the Department of Health and Human Services and the National Institutes of Health.

Back to bills

Gwenn’s Law

Last updated: 2/25/2026 · Introduced: 2/25/2026

Author: Josh Gottheimer (D-NJ)

TL;DR (AI)

This bill establishes a permanent Interagency Task Force to assess and coordinate federal activities related to rare diseases, with a focus on those disproportionately impacting women.
The bill directs the Secretary of Health and Human Services to implement two public awareness campaigns, each authorized to receive $10 million annually through 2031, to increase female participation in clinical trials and research programs related to bleeding and clotting disorders.
The bill mandates the Secretary of Health and Human Services to develop and publicly release an action plan within 180 days to incentivize research and development for rare diseases and conditions that disproportionately affect women.

119th Congressin committeeOfficial page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 4 more.

6 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account